Peptide Vials (GHK-Cu, 50 mg each): 5 days/week (1.02.0 mg/day): 8 weeks (~50 mg total) 1 vial 12 weeks (~90 mg total) 2 vials 16 weeks (~130 mg total) 3 vials 3/week (2 mg each): 8 weeks (~48 mg) 1 vial 12 weeks (~72 mg) 2 vials 16 weeks (~96 mg) 2 vials Insulin Syringes (U100, 2931 gauge): 5 days/week: Per week: 5 syringes 8 weeks: 40 syringes 12 weeks: 60 syringes 16 weeks: 80 syringes 3/week: Per week: 3 syringes 8 weeks: 24 syringes 12 weeks: 36 syringes 16 weeks: 48 syringes Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
The disadvantage is that small dosing errors become magnified
BPC157 and treatment of digestive system damage Studies indicate that BPC-157 has the ability to regenerate the gastric and intestinal mucosa, which makes it helpful in treating conditions such as stomach ulcers or intestinal inflammation
With compounding access limited, some patients have turned to gray-market peptide suppliers
While the injections themselves do not directly target the virus, they can support the cat's immune response, potentially slowing down the progression of the disease and improving the cat's quality of life
Sleep quality, mental clarity, and stress tolerance shift first